Hengerer Fritz H, Conrad-Hengerer Ina
Klin Monbl Augenheilkd. 2017 Aug;234(8):1035-1047. doi: 10.1055/s-0043-106820. Epub 2017 May 9.
Implanting phakic IOLs (PIOLs) in phakic eyes is regarded as an established option in refractive surgery for many years when treating high myopia, hyperopia or ametropia. Even for eyes which show a combination of refractive errors (including astigmatism) this can be an appropriate option. The surgery itself requires certain anatomical and refractive requirements, since, as with any intraocular procedure, there are different possibilities of complication depending on the chosen IOL. Therefore, any potential candidate for refractive surgery should be treated in accordance with the current recommendations of the German "Commission Refractive Surgery" (KRC) to achieve the best possible refractive outcome with maximum safety for patient and surgeon.This article will present the current options for surgery and IOLs with special focus on possibilities and limitations.
多年来,在治疗高度近视、远视或屈光不正时,在有晶状体眼内植入有晶状体眼人工晶状体(PIOL)被视为屈光手术中一种既定的选择。即使对于存在多种屈光不正(包括散光)组合的眼睛,这也可能是一种合适的选择。手术本身需要特定的解剖学和屈光条件,因为与任何眼内手术一样,根据所选的人工晶状体不同,会有不同的并发症可能性。因此,任何屈光手术的潜在候选者都应按照德国“屈光手术委员会”(KRC)的当前建议进行治疗,以便在确保患者和外科医生最大安全的前提下实现尽可能好的屈光效果。本文将介绍当前的手术选择和人工晶状体,特别关注其可能性和局限性。